4 Results for "

PCSK9 modulator

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PCSK9 modulator" in MCE Product Catalog:

  • Categories Recommended:
    More
Cat. No.: HY-146084
CAS No.: 2476490-18-1
Target:  

PCSK9

Research Areas:  

Metabolic Disease

PCSK9 modulator-3 is a PCSK9 modulator that reduces the secretion level of PCSK9 protein in HepG2 cells. PCSK9 modulator-3 exhibits metabolic stability in liver microsomes of mice and rats. PCSK9 modulator-3 can be used for the study of hyperlipidemia .
loading...
    loading...
Cat. No.: HY-128334
CAS No.: 2365416-53-9
Target:  

PCSK9

Research Areas:  

Metabolic Disease

PCSK9 modulator-2 (Compound 1) is a potent modulator of PCSK9 with an EC50 value of 202 nM. PCSK9 is a recently validated target for lowering low-density lipoprotein cholesterol (LDL-C). PCSK9 modulator-2 has the potential for the research of hyperlipidemia .
loading...
    loading...
Cat. No.: HY-146085
CAS No.: 2476490-20-5
Target:  

PCSK9

Research Areas:  

Metabolic Disease

PCSK9 modulator-4 (Compound 21) is a potent modulator of PCSK9 with an EC50 value of 0.15 nM. PCSK9 is a recently validated target for lowering low-density lipoprotein cholesterol (LDL-C). PCSK9 modulator-4 has the potential for the research of hyperlipidemia .
loading...
    loading...
Cat. No.: HY-N21887
CAS No.: 105214-48-0
Gypenoside LVI is an orally active dammarane-type triterpenoid compound found in Gynostemma pentaphyllum. Gypenoside LVI inhibits ERK and JNK phosphorylation, the NLRP3 inflammasome, and modulates M1 to M2 microglial polarization. Gypenoside LVI downregulates PCSK9 expression through a SREBP-independent pathway. Gypenoside LVI promotes cholesterol efflux via ABCG1 and SRB1, upregulates LXRα-mediated reverse cholesterol transport, and attenuates foam cell formation by reducing lipid accumulation and cholesterol uptake. Gypenoside LVI inhibits IL-6 and IL-1β secretion, reduces oxidative stress, neuroinflammation, microglial and astrocyte activation, and inhibits LPS-induced microglial proliferation. Gypenoside LVI can be used for research on atherosclerosis, hypercholesterolemia, depression, and non-small cell lung cancer .
loading...
    loading...